Primary Dermal Melanoma
Open Access
- 1 January 2004
- journal article
- observation
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 140 (1), 99-103
- https://doi.org/10.1001/archderm.140.1.99
Abstract
Background The termprimary dermal melanomahas been used to describe a subtype of melanoma confined to the dermis and/or subcutaneous fat that histologically simulates metastasis but is associated with an unexpectedly prolonged survival. We report 7 cases of primary dermal melanoma diagnosed from 1998 to 2002 with no identifiable junctional or epidermal component or nevoid precursor. Histopathologic and immunohistochemical features were compared with known cases of cutaneous metastasis and nodular melanoma in an attempt to differentiate this entity from clinical and pathologic mimics. Observations Seven patients had a single dermal and/or subcutaneous focus of melanoma. Metastatic staging workup findings were negative, including results fromsentinel node and imaging studies. Mean Breslow depth was 7.0 mm, and mean maximum tumor diameter was 6.2 mm. The study cohort showed 100% survival at mean follow-up of 41 months (range, 10-64 months). Immunohistochemical analysis with S100, HMB-45, Ki-67, CD34, and p75 antibodies showed no significant staining patterns compared with metastatic and nodular melanomas. Conclusions Primary dermal melanoma appears to be a distinct subtype of melanoma based on the excellent prognosis associated with this case series and others. Additional research focusing on cause, appropriate staging, and outcome of previously identified solitary dermal metastasis is warranted to further delineate this entity.Keywords
This publication has 10 references indexed in Scilit:
- Small bowel intussussception due to metastatic melanoma of unknown primary site. Case reportIl Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons, 2014
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- The p75 Neurotrophin Receptor, Relative to Other Schwann Cell and Melanoma Markers, Is Abundantly Expressed in Spindled MelanomasThe American Journal of Dermatopathology, 2001
- CD34-positive cellular blue neviNoteJournal of Cutaneous Pathology, 2001
- The spectrum of neurocristic cutaneous hamartoma: Clinicopathologic and immunohistochemical study of three casesAnnals of Diagnostic Pathology, 1998
- p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanomaJournal of Cutaneous Pathology, 1996
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Malignant blue nevusCancer, 1991
- Clinical Aspects of Unknown Primary MelanomaAnnals of Surgery, 1980
- Occult primary malignant melanoma: Factors influencing survivalBritish Journal of Surgery, 1977